1151P Evolution of biomarker testing among non-squamous/non-small cell lung cancer (NSCLC) patients (Pts) and impact on turnaround times (TAT)

Autor: Fan, Z., Tudor, R., Le, L., Law, J., Kuang, S., Meti, N., Fung, A., Perdrizet, K., Chen, K., Li, J., Ghumman, N., Ranich, L., Wei, C., Sabatani, P., Tsao, M-S., Leighl, N., Cabanero, M.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1076-S1076
Databáze: ScienceDirect